Intracellular Concentrations of Posaconazole in Different Compartments of Peripheral Blood

被引:44
作者
Farowski, Fedja [1 ]
Cornely, Oliver A. [1 ,2 ]
Vehreschild, Joerg J. [3 ]
Hartmann, Pia
Bauer, Tim [4 ]
Steinbach, Angela [1 ]
Rueping, Maria J. G. T. [1 ]
Mueller, Carsten [4 ]
机构
[1] Klinikum Univ Koln, Klin Studienzentrum Infektiol 2, Innere Med Klin 1, D-50924 Cologne, Germany
[2] Univ Cologne, ZKS Koln, BMBF 01KN0706, D-50924 Cologne, Germany
[3] Klinikum Univ Koln, Innere Med Klin 1, BMBF 01KI0771, D-50924 Cologne, Germany
[4] Klinikum Univ Koln, Inst Pharmakol, D-50924 Cologne, Germany
关键词
INTRAPULMONARY PHARMACOKINETICS; PHARMACODYNAMICS; ITRACONAZOLE; VORICONAZOLE;
D O I
10.1128/AAC.01407-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Therapeutic drug monitoring (TDM) of antifungal plasma concentrations is increasingly recommended. However, data on antifungal concentrations in the other compartments of the peripheral blood are limited. Hence, we collected 23 blood samples from 14 patients receiving posaconazole for prophylaxis of fungal infections. These samples were separated by double-discontinuous Ficoll-Hypaque density gradient centrifugation. The intracellular posaconazole concentrations of the obtained cells, i.e., the peripheral blood mononuclear cells (PBMCs), polymorphonuclear leukocytes (PMNs), and red blood cells (RBCs), were determined by liquid chromatography-tandem mass spectrometry. The intracellular concentrations of the PBMCs and PMNs were significantly higher than those of surrounding media (P < 0.001). The ratios between the intracellular and extracellular concentrations (C/E) were 22.5 +/- 21.2, 7.66 +/- 6.50, and 0.09 +/- 0.05 for the PBMCs, PMNs, and RBCs, respectively. Posaconazole reaches high concentrations within human PBMCs and PMNs and is, to a lesser extent, present in RBCs. The high intracellular concentrations might contribute to posaconazole efficacy and distribution.
引用
收藏
页码:2928 / 2931
页数:4
相关论文
共 16 条
[1]   Uptake and intracellular activity of voriconazole in human polymorphonuclear leucocytes [J].
Ballesta, S ;
García, I ;
Perea, EJ ;
Pascual, A .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (05) :785-787
[2]   Antifungal effect of voriconazole on intracellular Candida glabrata, Candida krusei and Candida parapsilosis in human monocyte-derived macrophages [J].
Bopp, Lawrence H. ;
Baltch, Aldona L. ;
Ritz, William J. ;
Michelsen, Phyllis B. ;
Smith, Raymond P. .
JOURNAL OF MEDICAL MICROBIOLOGY, 2006, 55 (07) :865-870
[3]   Intrapulmonary pharmacokinetics and pharmacodynamics of itraconazole and 14-hydroxyitraconazole at steady state [J].
Conte, JE ;
Golden, JA ;
Kipps, J ;
McIver, M ;
Zurlinden, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (10) :3823-3827
[4]   Intrapulmonary Pharmacokinetics and Pharmacodynamics of Posaconazole at Steady State in Healthy Subjects [J].
Conte, John E., Jr. ;
Golden, Jeffrey A. ;
Krishna, Gopal ;
McIver, Marina ;
Little, Emily ;
Zurlinden, Elisabeth .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (02) :703-707
[5]  
Cornely OA, 2008, IMPROVING DIAGNOSIS
[6]   Posaconazole: a next-generation triazole antifungal [J].
Farowski, Fedja ;
Vehreschild, Joerg ;
Cornely, Oliver A. .
FUTURE MICROBIOLOGY, 2007, 2 (03) :231-243
[7]   Quantitation of Azoles and Echinocandins in Compartments of Peripheral Blood by Liquid Chromatography-Tandem Mass Spectrometry [J].
Farowski, Fedja ;
Cornely, Oliver A. ;
Vehreschild, Joerg J. ;
Hartmann, Pia ;
Bauer, Tim ;
Steinbach, Angela ;
Rueping, Maria J. G. T. ;
Mueller, Carsten .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (05) :1815-1819
[8]  
HARLAN JM, 1985, BLOOD, V65, P513
[9]   Therapeutic drug monitoring for triazoles [J].
Hope, William W. ;
Billaud, Eliane M. ;
Lestner, Jodie ;
Denning, David W. .
CURRENT OPINION IN INFECTIOUS DISEASES, 2008, 21 (06) :580-586
[10]   UPTAKE AND INTRACELLULAR ACTIVITY OF FLUCONAZOLE IN HUMAN POLYMORPHONUCLEAR LEUKOCYTES [J].
PASCUAL, A ;
GARCIA, I ;
CONEJO, C ;
PEREA, EJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (02) :187-190